Meet the Jury

Honourees of the 2024 Canadian Healthcare Industry Awards are selected by a four-person jury comprised of thought leaders in the Canadian life sciences, who evaluate nominees according to criteria outlined by the nomination form for each category.

John Simmons

Lea Prevel Katsanis

Dr. Jeffrey Habert


Learn More:

John Simmons

John Simmons is a seasoned global healthcare executive with experience in both global leadership and country level general management roles. John was most recently the CEO of AceAge Inc, a Canadian based healthcare technology firm which was successfully sold to private equity.  Prior to AceAge, John was the Canadian General Manager with Abbott Diagnostics. His career spans senior executive roles with Becton Dickinson USA and Canada, Philips Healthcare, Johnson & Johnson and KCI Medical and has been highlighted by a proven ability to build strong teams and excellent relationships with customers, industry groups, external partners and other key stakeholders.


John has served on a number of Boards and was recently appointed to the Board of Directors for Southlake Regional Health Centre.  He was a member of the Board of Directors at Medtech Canada (a national association supporting Canada’s innovative medical technology industry) for almost 10 years.  He was on the Executive Committee for most of that time, served as Treasurer and concluded his time as Chair of the Board.  Previous board roles include serving on the Executive Committee and as Treasurer of the Board of Directors for the Juvenile Diabetes Research Foundation in Northern New Jersey. 


John holds a Bachelor of Science with Honours from Queen’s University and an MBA from Simon Fraser University. 


Lea Prevel Katsanis

Lea Prevel Katsanis is a Professor in the Department of Marketing. Prior to joining Concordia in 1992, she obtained significant marketing experience in the pharmaceutical industry and held various positions in market research, sales, product management, strategic planning, and licensing and acquisition for three Fortune 500 corporations. She earned an BA from Vassar College, an MBA from New York University and a PhD from George Washington University.


Her research focuses on three areas of the marketing discipline: pharmaceutical marketing and advertising, branding and brand management; and social marketing/public policy. Katsanis has written numerous articles in publications including the Journal of Consumer Marketing, Health Marketing Quarterly, the International Journal of Pharmaceutical Marketing and Management, Journal of Product and Brand Management, and International Marketing Review. She has also presented papers at key marketing conferences such as the AMA Public Policy Conference, in addition to many invited presentations and workshops.  Several of her works were selected as the Lead Article for their respective issues. She has received both external and internal funding for her research.  She is on the Editorial Boards for the Journal of Consumer Marketing, the Journal of Product and Brand Management, and the International Journal of Pharmaceutical and Healthcare Marketing. She is the author of the book Global Issues in Pharmaceutical Marketing. The book was an Amazon “hot new read” in the areas of Industrial Marketing and Global Marketing when it was launched.


Katsanis has received recognition from her students for her high quality teaching. She teaches in the BComm, the MBA and the MSc Programs. She has taught a variety of courses including Advertising, Marketing Strategy, Marketing Management, Sales Management and currently, Pharmaceutical Marketing, Personal Selling, and Product Strategy and Innovation.


She has also served the University in two key administrative capacities: MBA Director (1998-2000) and Chair, Department of Marketing (2006-2012), and served as a member of the University Senate.

Jeffrey Habert

Dr. Jeffrey Habert is a family physician in Thornhill, ON for the last 33 years. He is an Assistant Professor in the Department of Family and Community Medicine at the University of Toronto and an investigating coroner for the city of Toronto. He is the co-director of the CPD Network, a physician organization devoted to the creation of medical education programs.


He has an interest in the development and use of clinical practice guidelines and has participated on committees to establish guidelines in the areas of stroke, ASA in primary prevention, depression and thrombosis.


He is the previous co-chair of the Thrombosis Canada Clinical Guides Committee. His clinical interests are varied, and include diabetes, obesity, respiratory disease, depression, ADHD, insomnia, thrombosis/stroke and osteoporosis. He has spoken nationally and published articles in the above mentioned areas.

Mike Cloutier

Mike Cloutier is a recently retired accomplished business leader and consultant with over 45 years in the Life Sciences sector. Over the past 25 years, Mike was General Manager, President and CEO of five major pharmaceutical firms and one Not for Profit organization, the Canadian Diabetes Association (now Diabetes Canada). In 2017, Mike founded a Canadian-based global consulting practice, Accelera Canada Ltd. that was acquired by Eversana. The organization provides unique and unparalleled “one stop concierge support” to US and European-based biotech/pharmaceutical companies exploring commercial entry to Canada. Mike also co-founded Novescend to provide consultation, in-licensing and distribution to US/EU-based medical device and diagnostic innovators.


Prior to his role at Accelera Canada, Mike led organizations with interests in the Orphan and Rare disease market segments. As the General Manager and President of PTC Therapeutics Canada and InterMune Canada Inc., he ensured the delivery of tremendous support to patients and caregivers. These companies drove exceptional results in terms of optimal access for patients in need and financial success.


Mike is active on a strategic level sitting and leading a variety of Boards. He chairs the Board of Directors at Arylide Canada, sits on the Boards of OBIO and Alimentiv. He has previously Chaired the Board of Directors at Scientus, Merus Labs International and was a Board Director at Joule, a subsidiary of the Canadian Medical Association. As a result, Mike has an extensive network throughout Canada, the US and International circles.


Mike is a respected, dedicated philanthropist and has served on numerous Boards as a volunteer including the Canadian Stroke Network, Sheridan College Institute of Technology and Advanced Learning and the Canadian Orthopaedic Foundation. Mike is the past Fundraising Chair of the Hazel McCallion Academic Learning Centre at the University of Toronto Mississauga. Among his many accomplishments, Mike was inducted to the Sheridan College School of Business Marketing Hall of Fame and the Canadian Pharmaceutical Marketing Hall of Fame.